CompaniesAncora Pharmaceuticals

Ancora Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

103

By Phase

PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
NCT06597058
Hover over trial bars to see details

Recent Trials

NCT06597058Lead Sponsor
Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill
PHASE2Active, not recruiting
103 participants
Started: Oct 16, 2024 · Completed: Feb 15, 2026
Funding History (1)
D
Nov 24, 2009
Filing
Related Companies
Corden Pharm
acquired
Ancora Pharmaceuticals | Biotech Hunter | Biotech Hunter